HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TAT-PROTEIN STIMULATES THE PRODUCTION OF INTERLEUKIN-6 (IL-6) BY PERIPHERAL-BLOOD MONOCYTES

被引:0
作者
ZAULI, G
FURLINI, G
RE, MC
MILANI, D
CAPITANI, S
LAPLACA, M
机构
来源
MICROBIOLOGICA | 1993年 / 16卷 / 02期
关键词
TAT-PROTEIN; HIV-1; IL-6; GM-CSF; TNF-ALPHA;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this study we evaluated the effect of human immunodeficiency virus type 1 (HIV-1) recombinant tat-protein on the production of interleukin-6 (IL-6), granulocyte/macrophage colony stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF-alpha) by purified peripheral blood monocytes. Whereas no effects were observed on TNF-alpha and GM-CSF production, recombinant tat-protein was able to induce the production of IL-6 by peripheral blood monocytes in a dose-dependent fashion for concentrations ranging from 1 ng/ml to 1 mug/ml. Pre-exposure of tat-protein with a polyclonal neutralizing anti-tat antibody (dilution 1:100) completely abrogated the tat-dependent increase in IL-6 production. The ability of tat-protein to selectively stimulate the production of IL-6 by peripheral blood monocytes could help to explain the presence of elevated levels of IL-6 in the serum of HIV-1 seropositive individuals, especially in patients in advanced stages of the disease with an active viral replication.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 47 条
[1]   RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TAT PROTEIN SEQUENTIALLY UP-REGULATES IL-6 AND TFG-BETA-1 MESSENGER-RNA EXPRESSION AND PROTEIN-SYNTHESIS IN PERIPHERAL-BLOOD MONOCYTES [J].
GIBELLINI, D ;
ZAULI, G ;
RE, MC ;
MILANI, D ;
FURLINI, G ;
CARAMELLI, E ;
CAPITANI, S ;
LAPLACA, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (02) :261-267
[2]   THE TAT GENE AND PROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
CAPUTO, A ;
GROSSI, MP ;
ROSSI, C ;
CAMPIONI, D ;
BALBONI, PG ;
CORALLINI, A ;
BARBANTIBRODANO, G .
MICROBIOLOGICA, 1995, 18 (01) :87-110
[3]   The human immunodeficiency virus type-1 (HIV-1) Tat protein and bcl-2 gene expression [J].
Zauli, G ;
Gibellini, D .
LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) :551-560
[4]   DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSCRIPTS IN PERIPHERAL-BLOOD LYMPHOCYTES BY THE POLYMERASE CHAIN-REACTION [J].
BAGNARELLI, P ;
MENZO, S ;
MANZIN, A ;
VARALDO, PE ;
MONTRONI, M ;
GIACCA, M ;
CLEMENTI, M .
JOURNAL OF VIROLOGICAL METHODS, 1991, 32 (01) :31-39
[5]   INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AMONG RECIPIENTS OF ANTIBODY-POSITIVE BLOOD DONATIONS [J].
DONEGAN, E ;
STUART, M ;
NILAND, JC ;
SACKS, HS ;
AZEN, SP ;
DIETRICH, SL ;
FAUCETT, C ;
FLETCHER, MA ;
KLEINMAN, SH ;
OPERSKALSKI, EA ;
PERKINS, HA ;
PINDYCK, J ;
SCHIFF, ER ;
STITES, DP ;
TOMASULO, PA ;
MOSLEY, JW .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (10) :733-739
[6]   In vivo and in vitro modulatory effect of human immunodeficiency virus type-1 (HIV-1) Tat protein on protein kinase C activity [J].
Celeghini, C ;
Marchisio, M ;
Mischiati, C ;
Bertolaso, L ;
Capitani, S ;
Zauli, G .
INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (02) :349-354
[7]   6 STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATED IN JAPAN AND THEIR MOLECULAR PHYLOGENY [J].
SHIMIZU, N ;
TAKEUCHI, Y ;
NARUSE, T ;
INAGAKI, M ;
MORIYAMA, E ;
GOJOBORI, T ;
HOSHINO, H .
JOURNAL OF MOLECULAR EVOLUTION, 1992, 35 (04) :329-336
[8]   BLOCKING-ELISA FOR DETECTION OF SPECIFIC ANTIBODIES TO THE GLYCOPROTEINS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) [J].
TARDY, JC ;
BASSON, J ;
DOUGLAS, A ;
AYMARD, M .
JOURNAL OF MEDICAL VIROLOGY, 1990, 30 (03) :206-210
[9]   TNFα, IL-1β and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma [J].
Ikemoto, S ;
Sugimura, K ;
Yoshida, N ;
Wada, S ;
Yamamoto, K ;
Kishimoto, T .
ANTICANCER RESEARCH, 2000, 20 (1A) :317-321
[10]   MUTATIONAL ANALYSIS OF THE FINGERS AND PALM SUBDOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE [J].
BOYER, PL ;
FERRIS, AL ;
CLARK, P ;
WHITMER, J ;
FRANK, P ;
TANTILLO, C ;
ARNOLD, E ;
HUGHES, SH .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 243 (03) :472-483